Neoadjuvant therapy
Integration of molecular subtyping and immune profiling to predict pathologic complete response in HER2+ breast cancer treated with neoadjuvant dual HER2 therapy
Publication: ASCO 2026, Abstract #621 Authors: David Page Title: Read More